PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2147113
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2147113
The global computed tomography (CT) scanners market is experiencing strong growth driven by the increasing prevalence of chronic diseases, rising demand for early diagnosis, and continuous advancements in medical imaging technologies. According to the report, the global computed tomography (CT) scanners market size was valued at USD 7.80 billion in 2025. The market is projected to grow from USD 8.22 billion in 2026 to USD 13.63 billion by 2034, exhibiting a CAGR of 6.5% during the forecast period. In 2025, Asia Pacific dominated the market with a 44.87% share, supported by increasing healthcare investments, expanding diagnostic infrastructure, and a growing patient population requiring advanced imaging solutions.
Computed tomography (CT) scanners are advanced medical imaging systems used for the diagnosis, monitoring, and treatment planning of various diseases, including cancer, cardiovascular disorders, neurological conditions, respiratory diseases, and orthopedic disorders. These systems provide detailed cross-sectional images of internal body structures, enabling accurate disease detection and clinical decision-making.
The market growth is driven by increasing adoption of AI-enabled imaging systems, photon-counting CT technology, rising healthcare infrastructure development, and growing demand for faster and more accurate diagnostic procedures. Major players operating in the market include Siemens Healthineers AG, GE HealthCare, Canon Medical Systems Corporation, Koninklijke Philips N.V., Fujifilm Corporation, and United Imaging Healthcare Co., Ltd.
Market Definition and Scope
Computed tomography scanners are medical imaging devices that use X-ray technology and advanced computer processing to generate detailed images of internal organs, tissues, and blood vessels.
The market scope covers:
CT scanners are widely used across:
The market also includes advancements in AI-based reconstruction, photon-counting detectors, spectral CT imaging, and low-radiation imaging technologies.
Market Dynamics
Drivers
Rising Burden of Cancer, Cardiovascular Diseases, and Neurological Disorders Driving Market Growth
The increasing prevalence of chronic diseases is a major factor supporting CT scanners market growth. Rising cases of cancer, cardiovascular disorders, neurological diseases, respiratory conditions, and traumatic injuries are increasing demand for advanced diagnostic imaging technologies.
CT scanners play a critical role in:
The growing focus on early diagnosis and preventive healthcare is encouraging hospitals and diagnostic centers to invest in advanced CT systems.
According to the International Agency for Research on Cancer (IARC), global cancer cases exceeded 20 million annually in 2024, creating significant demand for oncology imaging solutions.
Trends
Growing Adoption of Artificial Intelligence and Photon-Counting CT Technology
The integration of artificial intelligence and photon-counting CT technology is emerging as a major market trend.
Modern CT systems are increasingly incorporating:
Photon-counting CT technology offers enhanced spatial resolution, improved tissue characterization, and advanced spectral imaging capabilities.
For instance, Siemens Healthineers introduced the FDA-cleared NAEOTOM Alpha photon-counting CT system, while GE HealthCare expanded its photon-counting CT technology portfolio.
Restraints
High Installation and Maintenance Costs of CT Systems
High acquisition, installation, and maintenance costs remain significant challenges for market growth.
Advanced CT systems require substantial investment for:
For example, a 16-slice CT scanner can cost approximately USD 285,000-360,000, while annual maintenance costs can be significantly high for advanced systems.
These costs may limit adoption among smaller healthcare facilities and developing regions.
Impact of COVID-19
The COVID-19 pandemic increased demand for CT imaging due to its importance in respiratory disease assessment and patient monitoring.
Although supply chain disruptions affected equipment manufacturing and installation activities, the pandemic highlighted the importance of advanced diagnostic imaging infrastructure. Increased healthcare investment and modernization programs supported market recovery.
By technology, the low slice CT segment dominated the market in 2025, supported by lower costs, widespread adoption in emerging markets, and suitability for multiple diagnostic applications. The mid slice segment is expected to grow at a CAGR of 5.7% during the forecast period.
By application, the oncology segment dominated the market in 2025, driven by increasing cancer prevalence and growing adoption of CT imaging for cancer detection, staging, and treatment monitoring. The segment is estimated to hold a 31.4% share in 2026. The neurology segment is expected to grow at a CAGR of 6.0%.
By modality, the O-arm segment dominated the market in 2025, supported by increasing adoption in surgical navigation and complex procedures. The segment is projected to hold a 67.8% share in 2026.
By end user, the hospitals & ambulatory surgical centers (ASCs) segment dominated the market, driven by high imaging volumes, advanced healthcare infrastructure, and increasing diagnostic procedures. The segment is projected to hold a 60.1% share in 2026.
Asia Pacific leads the global computed tomography (CT) scanners market, valued at USD 3.50 billion in 2025, driven by increasing healthcare infrastructure investments, rising chronic disease burden, and growing demand for advanced diagnostic systems in China, India, and Japan. North America is the second-largest region, projected to reach USD 1.70 billion in 2026, supported by advanced healthcare facilities, high diagnostic imaging adoption, and technological innovation. Europe is witnessing steady growth due to increasing early diagnosis awareness, healthcare modernization, and expansion of advanced imaging facilities, while Latin America and the Middle East & Africa are experiencing gradual growth supported by healthcare investments and improved access to diagnostic technologies.
Competitive Landscape
The market is highly consolidated, with leading companies focusing on technological innovation, AI integration, advanced imaging solutions, and global distribution expansion. Key players include Siemens Healthineers AG, GE HealthCare, Canon Medical Systems Corporation, Koninklijke Philips N.V., Fujifilm Corporation, United Imaging Healthcare, Neusoft Medical Systems, and Carestream Health.
Key Industry Developments
Report Coverage
The global computed tomography (CT) scanners market report provides detailed analysis of market size for 2025, 2026, and 2034, including market dynamics, trends, growth drivers, restraints, segmentation analysis, regional insights, technological advancements, competitive landscape, partnerships, mergers & acquisitions, and key medical imaging industry developments.
Conclusion
Growing from USD 7.80 billion in 2025 to USD 13.63 billion by 2034, the global computed tomography (CT) scanners market is expected to witness significant growth due to rising chronic disease prevalence, increasing demand for early diagnosis, healthcare infrastructure expansion, and adoption of AI-enabled and photon-counting CT technologies. Advanced imaging solutions will create strong opportunities for market players. However, high installation costs, maintenance expenses, radiation safety concerns, and regulatory requirements will remain key challenges during the forecast period.
Segmentation By Technology, Application, Modality, End-User, and Region
By Technology
By Application
By Modality
By End-User
By Region